Previous 10 | Next 10 |
home / stock / invvy / invvy news
The following slide deck was published by Indivior PLC in conjunction with their 2022 Q1 earnings call. For further details see: Indivior PLC 2022 Q1 - Results - Earnings Call Presentation
Indivior PLC ADR press release (OTCPK:INVVY): Q1 Non-GAAP EPS of $0.06. Revenue of $207M (+15.0% Y/Y). On an adjusted basis, Q1 2022 operating profit was $54M (+6% vs. adj. Q1 2021: $51M). FY 2022 guidance issued by Indivior on February 16, 2022, is unchanged. For further details see: I...
Indivior Announces Q1 2022 Financial Results PR Newswire SLOUGH, U.K. and RICHMOND, Va. , April 28, 2022 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced its financial results for the period ending March 31, 2022 . The earnings releas...
Indivior Statement on Nationwide Increases in Fentanyl-Related Mass-Overdose Events PR Newswire Expanding access to medication to treat opioid use disorder is a critical part of the solution RICHMOND, Va. , April 12, 2022 /PRNewswire/ -- Indivior ...
Indivior (OTCPK:INVVY) announced modeling data testing the interaction between buprenorphine, a treatment for opioid use disorder (OUD), and fentanyl, a synthetic opioid, to check how buprenorphine can reduce fentanyl-induced respiratory depression. The company said the modeling data ind...
Indivior Publishes Modeling Data Showing Buprenorphine May Mitigate Fentanyl-Induced Respiratory Depression in Chronic Opioid Users PR Newswire Data available online and in an upcoming print issue of JCI Insight, a peer-reviewed journal RICHMOND, Va. , ...
Indivior to Commence Formal Shareholder Consultations on Additional US Listing PR Newswire RICHMOND, Va. , March 31, 2022 /PRNewswire/ -- Indivior PLC, (LON: INDV) today announced that further to its announcement on February 16, 2022 , it is comm...
Indivior PLC (INVVY) Q4 2021 Results Earnings Conference Call February 16, 2022, 08:00 AM ET Company Participants Mark Crossley - Chief Executive Officer Ryan Preblick - Chief Financial Officer Christian Heidbreder - Chief Scientific Officer Conference Call Participants Christian Glennie - St...
The following slide deck was published by Indivior PLC in conjunction with their 2022 Q4 earnings call. For further details see: Indivior PLC 2022 Q4 - Results - Earnings Call Presentation
Indivior PLC ADR press release (OTCPK:INVVY): Q4 Non-GAAP EPS of $0.03. Revenue of $222M (+20.0% Y/Y). For further details see: Indivior PLC ADR Non-GAAP EPS of $0.03, revenue of $222M
News, Short Squeeze, Breakout and More Instantly...
Indivior to Host Analyst Teach-in Event in New York City; Reconfirms Full Year 2024 Guidance PR Newswire RICHMOND, Va. , May 23, 2024 /PRNewswire/ -- Indivior PLC (LSE: INDV; Nasdaq: INDV), a leading addiction treatment company, announced that in anticipation o...
Indivior Announces Q1 2024 Financial Results PR Newswire SLOUGH, United Kingdom and RICHMOND, Va. , April 25, 2024 /PRNewswire/ -- Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024 . The earnings re...
Indivior Announces Publication Demonstrating that OPVEE® (nalmefene) Nasal Spray Rapidly Reverses Effects of Opioid-Induced Respiratory Depression in Head-to-Head Study Against Intranasal Naloxone PR Newswire This head-to-head pharmacodynamic study in healthy volunteers...